Cita APA (7a ed.)
Grinshpun, A., Russo, D., Ma, W., Verma, A., Hermida-Prado, F., Sherman, S., . . . Jeselsohn, R. (2024). Pure estrogen receptor antagonists potentiate capecitabine activity in ESR1-mutant breast cancer. NPJ Breast Cancer. https://doi.org/10.1038/s41523-024-00647-1
Cita Chicago Style (17a ed.)
Grinshpun, Albert, et al. "Pure Estrogen Receptor Antagonists Potentiate Capecitabine Activity in ESR1-mutant Breast Cancer." NPJ Breast Cancer 2024. https://doi.org/10.1038/s41523-024-00647-1.
Cita MLA (9a ed.)
Grinshpun, Albert, et al. "Pure Estrogen Receptor Antagonists Potentiate Capecitabine Activity in ESR1-mutant Breast Cancer." NPJ Breast Cancer, 2024, https://doi.org/10.1038/s41523-024-00647-1.
Precaución: Estas citas no son 100% exactas.